Morganti & Co., P.C., a cross border shareholder’s rights law firm, confirms that it has commenced a shareholder class action lawsuit against Wayland Group Corp. (“Wayland) (“WAYL”), formerly known as Maricann Group Inc.
It has been over 12 months since Wayland has published its continuous disclosure investor documents and now its securities remain halted.
This securities class action relates to Wayland conducting multiple offerings thereby raising tens of millions of dollars from investors, and making false statements about how the raised capital would be used, the status of the build-out at the Langton Facility, and its the pro forma output and revenues that would be achieved from the additional cannabis that would be produced.
The shareholders that received marketing materials from Wayland and its underwriters that sold the shares are encouraged to contact the Firm to discuss what those materials disclosed.
About Morganti & Co.
The Firm also represents investors in litigation against Aphria Inc. (TSX: “APHA”), Auxly Cannabis Group Inc. (TSX: “XLY”), FSD Pharma, Inc. (TSX: “HUGE”), HEXO Corp. (HEXO.TO), and Namaste Technologies Inc. (TSXV: “N”).
This press release may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules.